Global GMP Cell Banking Market Growth (Status and Outlook) 2023-2029

Global GMP Cell Banking Market Growth (Status and Outlook) 2023-2029

Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages. A cell bank comprises of a storage facility for cells extracted from different body fluids and organ tissue so that they can be used in the future. Stored cells contain detailed characterization of the cell line thereby decreasing chances of cross contamination. And GMP cell banking services consists of outsourcing gathering, storing, characterization, and testing facilities of cell lines, tissues, and cells. GMP basically stands for “Good Manufacturing Practice.”

LPI (LP Information)' newest research report, the “GMP Cell Banking Industry Forecast” looks at past sales and reviews total world GMP Cell Banking sales in 2022, providing a comprehensive analysis by region and market sector of projected GMP Cell Banking sales for 2023 through 2029. With GMP Cell Banking sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GMP Cell Banking industry.

This Insight Report provides a comprehensive analysis of the global GMP Cell Banking landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GMP Cell Banking portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GMP Cell Banking market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP Cell Banking and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP Cell Banking.

The global GMP Cell Banking market size is projected to grow from US$ 555.1 million in 2022 to US$ 1283.3 million in 2029; it is expected to grow at a CAGR of 12.7% from 2023 to 2029.

Global key players of GMP cell banking include Charles River, Thermo Fisher, Lonza, Wuxi Apptec, etc. Global top five manufacturers hold a share over 55%. In terms of product, mammalian cell is the largest segment, with a share over 63%. And in terms of application, the largest application is biopharmaceutical companies, with a share over 75%.

This report presents a comprehensive overview, market shares, and growth opportunities of GMP Cell Banking market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Mammalian Cell
Microbial Cell
Insect Cell
Others

Segmentation by application
Biopharmaceutical Companies
Contract Manufacturing Organizations

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Thermo Fisher
Lonza
Wuxi Apptec
Eurofins Scientific
Merck KGaA
SGS Life Sciences
Sartorius
Catalent
Goodwin Biotechnology
Texcell

Please note: The report will take approximately 2 business days to prepare and deliver.